48,830
edits
Difference between revisions of "Squamous cell carcinoma"
Jump to navigation
Jump to search
→IHC
(→IHC) |
(→IHC) |
||
| Line 228: | Line 228: | ||
*[[p63]] +ve. | *[[p63]] +ve. | ||
*K903 +ve. | *K903 +ve. | ||
*p16 +ve/-ve -- dependent on site, +ve favours non-lung SCC.<ref name=pmid20823766/> | *[[p16]] +ve/-ve -- dependent on site, +ve favours non-lung SCC.<ref name=pmid20823766/> | ||
*[[p40]] +ve. | |||
Note: | Note: | ||
*Immunostains not particularly helpful for establishing primary site of squamous cell carcinoma. p16 may be helpful but is not definitive for non-lung.<ref name=pmid20823766>{{cite journal |vauthors=Pereira TC, Share SM, Magalhães AV, Silverman JF |title=Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases |journal=Appl. Immunohistochem. Mol. Morphol. |volume=19 |issue=1 |pages=10–4 |date=January 2011 |pmid=20823766 |doi=10.1097/PAI.0b013e3181ecaf1c |url=}}</ref> | *Immunostains not particularly helpful for establishing primary site of squamous cell carcinoma. p16 may be helpful but is not definitive for non-lung SCC.<ref name=pmid20823766>{{cite journal |vauthors=Pereira TC, Share SM, Magalhães AV, Silverman JF |title=Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases |journal=Appl. Immunohistochem. Mol. Morphol. |volume=19 |issue=1 |pages=10–4 |date=January 2011 |pmid=20823766 |doi=10.1097/PAI.0b013e3181ecaf1c |url=}}</ref> | ||
=See also= | =See also= | ||